About Septerna
Septerna is on a mission to make the promise of future GPCR medicines a reality for patients. Combining the latest advances in biochemical, structural and computational drug discovery approaches, we have built an industrialized platform to precisely control and modulate GPCR biology and pharmacology to discover and develop new high-impact medicines. With our Native Complex™ platform, we are opening a new frontier in GPCR small molecule discovery technologies to expand the druggable GPCR landscape.
We are always looking for talented scientists, drug hunters, and business professionals to join our mission to launch a new era of GPCR medicines. If you’re passionate about innovation, energized by teamwork, and fueled by the desire to change patient lives, join us and become a part of the Septerna story!
|
|
|
51-200 employees
View all Septerna employees
|
|
Biotechnology Research
|
|
250 E Grand Ave, 65, South San Francisco, California 94080, US
|
|
None
|
Septerna Alternatives
Frequently Asked Questions about Septerna
The decision makers in Septerna are Amer Mirza, Angela Chen Fox, Angela Chen Fox, etc. Click to Find Septerna decision makers emails.
Septerna Staff Directory
Search Septerna Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
